Next »
Annals of Emergency Medicine
Volume 44, Issue 1
, Pages 12-19
, July 2004
Delta creatine kinase–MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non–ST-segment elevation acute coronary syndromes
References
- . Recommendations for the use of cardiac markers in coronary artery disease. Clin Chem. 1999;45:1104–1121
- . The sensitivity of cardiac markers: an evidence-based approach. Clin Chem Lab Med. 1999;37:1097–1106
-
Bedside multimarker testing for risk stratification in chest pain units.
Circulation. 2001;103:1832–1837
- Ninety-minute accelerated critical pathway for chest pain evaluation. Am J Cardiol. 2001;88:611–617
- Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation. 2001;104:1483–1488
- . Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol. 2000;36:959–969
- . European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J. 2002;144:981–986
- Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations. Am Heart J. 2002;144:957–980
-
Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction.
Heart. 2002;88:343–347
- Impact of the troponin standard on the prevalence of acute myocardial infarction. Am Heart J. 2003;146:446–452
- Serial CK-MB testing during the emergency department evaluation of chest pain: utility of a 2 hour delta CK-MB of +1.6 ng/ml. Am Heart J. 1998;136:237–244
- . Delta CK-MB outperforms delta Troponin I at 2 hours during the initial ED evaluation of chest pain. Am J Emerg Med. 2000;18:1–8
- Value of serial myoglobin levels in the early diagnosis of patients admitted for acute myocardial infarction. Ann Emerg Med. 1994;24:704–708
- Serial myoglobin levels for patients with possible myocardial infarction. Acad Emerg Med. 1996;3:590–597
- Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CK-MB for ruling out acute myocardial infarction in the emergency department. Ann Emerg Med. 1994;24:665–671
- The Erlanger chest pain evaluation protocol: a one-year experience with serial 12-lead ECG monitoring, two-hour delta serum marker measurements, and selective nuclear stress testing to identify and exclude acute coronary syndromes. Ann Emerg Med. 2002;40:584–594
-
.
Abbott Technical Bulletin: Abbott Axsym System CK-MB.
Abbott Park, IL: Abbott Laboratories; 1997;
List No. 7A57
-
.
Abbott Technical Bulletin: Abbott Axsym System Myoglobin.
Abbott Park, IL: Abbott Laboratories; 1997;
List No. 3E43
-
.
Abbott Technical Bulletin: Abbott Axsym System Troponin-I.
Abbott Park, IL: Abbott Laboratories; 1997;
List No. 3C29
- . Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease. Am J Med. 1997;102:350–356
- Initial ECG in Q wave and non-Q wave myocardial infarction. Ann Emerg Med. 1989;18:741–746
-
Medcalc: a new computer program for medical statistics.
Comput Methods Prog Biomed. 1995;48:257–262
- . Clinical utility of likelihood ratios. Ann Emerg Med. 1998;31:391–397
- . A method of comparing the areas under receiving operating characteristic curves derived from the same cases. Radiology. 1983;148:839–843
-
.
Statistical Methods for Rates and Proportions.
2nd ed.. New York, NY: John Wiley & Sons; 1981;
112–119
-
.
Epidemiologic Research.
Belmont, CA: Lifetime Learning Publications; 1982;
300–302
- The prognostic significance of serial myoglobin, troponin I, and creatine kinase-MB measurements in patients evaluated in the emergency department for acute coronary syndromes. Ann Emerg Med. 2003;42:343–350
☆ Author contributions: FMF conceived the study and obtained research funding. All authors were involved in conception and design of the study. FMF and RHC were responsible for analysis and interpretation of data. FMF drafted the manuscript, and all authors contributed substantially to its revision. FMF takes responsibility for the paper as a whole.
☆☆ Presented at the American College of Emergency Physicians Research Forum, Seattle, WA, October 15, 2002.
★ Supported by unrestricted research grants from Phillips Medical Systems (formerly Hewlett-Packard), Millennium Pharmaceuticals Inc. (formerly Cor Therapeutics), Bristol-Myers Squibb Medical Imaging (formerly DuPont RadioPharmaceuticals), and EmCare, Inc.
★★ Reprints not available from the authors.
PII: S0196-0644(04)00094-0
doi: 10.1016/j.annemergmed.2004.02.003
© 2004 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.
Next »
Annals of Emergency Medicine
Volume 44, Issue 1
, Pages 12-19
, July 2004
